 | • レポートコード：B-MOR-05338 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、プレシジョンメディシン（精密医療）の世界市場について調べ、プレシジョンメディシン（精密医療）の世界規模、市場動向、市場環境、技術別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・プレシジョンメディシン（精密医療）の世界市場インサイト ・プレシジョンメディシン（精密医療）の世界市場環境 ・プレシジョンメディシン（精密医療）の世界市場動向 ・プレシジョンメディシン（精密医療）の世界市場規模 ・プレシジョンメディシン（精密医療）の世界市場規模：技術別 ・プレシジョンメディシン（精密医療）の世界市場規模：用途別 ・プレシジョンメディシン（精密医療）の世界市場：地域別市場規模・分析 ・プレシジョンメディシン（精密医療）の北米市場規模・予測 ・プレシジョンメディシン（精密医療）のアメリカ市場規模・予測 ・プレシジョンメディシン（精密医療）のヨーロッパ市場規模・予測 ・プレシジョンメディシン（精密医療）のアジア市場規模・予測 ・プレシジョンメディシン（精密医療）の日本市場規模・予測 ・プレシジョンメディシン（精密医療）の中国市場規模・予測 ・プレシジョンメディシン（精密医療）のインド市場規模・予測 ・プレシジョンメディシン（精密医療）の韓国市場規模・予測 ・関連企業情報・競争状況 |
The precision medicine market is expected to witness a CAGR of 9.7% during the forecast period. North America dominates the global market due to high incidence of cancer and government initiatives in the region.
Increasing Online Collaborative Forums
Precision medicine is based on the genetic profile of a patient and the way a particular drug can work for a specific genetic type. Drug development and discovery in precision medicine requires a collaborative effort. The data from clinical research and other gene sequencing forums are important in understanding the drug targets for personalized medicine. Sharing the information available through online collaborations helps in exchanging useful information between different research groups, thus, increasing online collaborative forums, which is further fuelling the growth of the global precision medicine market.
Additionally, increasing efforts to characterize genes and advancement in cancer biology are also responsible for the growth of the global precision medicine market.
Perils of Data Sharing
Expansion of healthcare with huge volume and velocity of data has encouraged clinicians and hospitals to use analytics. In spite of all the benefits provided by healthcare analytics there are still barriers to adopt healthcare IT systems; data integrity is one such barrier. Well-established organizations are facing difficulty in capturing data from different sources. Data integrity has been impacted by duplicate records and patient misidentification. Criminals are stealing information through breached cyber security (identity theft) to reach beyond the victim’s bank accounts. The integrity of data in health IT systems can also be compromised due to data entry errors, missing data or delayed data delivery, copying and pasting older information into a new report, use of both paper and electronic systems for patient care, and patient/data association errors. Since inaccurate data has the potential to become a major health risk for patients and a huge liability for providers, it is a key factor restraining the growth of the precision medicine market.
Additionally, high cost associated with precision medicine and declining trends in FDA Pharmacotherapy approval rate are restraining the growth of the global precision medicine market.
North America Dominating the Market
The precision medicine market is expected to witness a CAGR of 9.7% during the forecast period. The US precision medicine market accounted for the largest regional share in 2017, owing to high prevalence of cancer, coupled with favorable regulatory scenario in the country. Numerous awareness campaigns and initiatives organized by government and private associations and societies, to increase awareness levels, will propel industry expansion. For example, the launch of Precision Medicine Initiative (PMI) by President Barack Obama in 2015 for developing innovative solutions for chronic diseases, such as cancer, based on genomic, environment and lifestyle characteristics of patients will also fuel the regional market growth.
Key Developments in the Market
• March 2017: NanoString launched nCounter Low RNA Input Kit, a product that generates high-quality gene expression profiling of up to 800 gene targets from as little as 1 ng of sample
Major Players: BIOCRATES LIFE SCIENCES AG, NANOSTRING TECHNOLOGIES, INTOMICS, FERRER INCODE, PFIZER, EAGLE GENOMICS LTD, TEVA PHARMACEUTICALS, LABORATORY CORPORATION OF AMERICA HOLDINGS, MEDTRONIC, NOVARTIS, QIAGEN, QUEST DIAGNOSTICS, and ROCHE HOLDING AG, AMONGST OTHERS.
Reasons to Purchase the Report
• Current and future precision medicine market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 month analyst support, along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)
6.1 Market Driver
6.1.1 Increasing Online Collaborative Forums
6.1.2 Increasing Efforts to Characterize Genes
6.1.3 Advancement in Cancer Biology
6.2 Market Restraints
6.2.1 Perils of Data Sharing
6.2.2 High Cost Associated with Precision Medicine
6.2.3 Declining Trends in FDA Pharmacotherapy Approval rate
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Big Data Analytics
7.1.2 Bioinformatics
7.1.3 Gene Sequencing
7.1.4 Drug Discovery
7.1.5 Companion Diagnostics
7.1.6 Others
7.2 By Application
7.2.1 Oncology
7.2.2 CNS
7.2.3 Immunology
7.2.4 Respiratory
7.2.5 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 Biocrates Life Sciences Ag
9.2 Nanostring Technologies
9.3 Intomics
9.4 Ferrer Incode
9.5 Pfizer
9.6 Eagle Genomics Ltd
9.7 Teva Pharmaceuticals
9.8 Laboratory Corporation of America Holdings
9.9 Medtronic
9.10 Novartis
9.11 Qiagen
9.12 Quest Diagnostics
9.13 Roche Holding Ag
10. Future Outlook of the Market